Skip to main content
Top
Published in: Journal of Bone and Mineral Metabolism 6/2020

01-11-2020 | Osteoarthrosis | Original Article

High bone turnover state under osteoporotic changes induces pain-like behaviors in mild osteoarthritis model mice

Authors: Kenta Kiyomoto, Kousuke Iba, Megumi Hanaka, Koji Ibe, Hikaru Hayakawa, Atsushi Teramoto, Makoto Emori, Toshihiko Yamashita

Published in: Journal of Bone and Mineral Metabolism | Issue 6/2020

Login to get access

Abstract

Introduction

Our previous studies demonstrated that a high bone turnover state under osteoporotic changes decreased the threshold of skeletal pain. Recent studies reported that the incidence of joint pain due to osteoarthritis (OA) in postmenopausal women was higher than that in males even with the same radiographic OA grade. The aim of this study was to evaluate whether a high bone turnover state affects the induction of pain-like behaviors in mild OA model mice.

Materials and Methods

We established mild OA model mice with accompanying osteoporotic changes by monosodium iodoacetate injection after ovariectomy. We assessed pain-like behaviors by von Frey test and paw-flick test; histological changes in OA joints; the expression of Runx2, Osterix, Osteocalcin, and Rankl; bone micro-architecture by μCT and measured serum tartrate-resistant acid-phosphatase 5b levels in the model mice.

Results

Pain-like behaviors in mice with OA and osteoporotic changes were significantly increased in comparison with those in OA mice without osteoporotic changes. The severity of histological OA changes did not differ significantly between the OA mice with and without osteoporotic changes. Bisphosphonate significantly improved pain-like behaviors accompanied with improvement in the high bone turnover state in the OA mice with osteoporosis, while it had no significant effect on pain-like behaviors in the OA mice without osteoporosis. In addition, the improvement was maintained for more than 4 weeks even after the discontinuation of bisphosphonate treatment.

Conclusion

These results indicated that a high bone turnover state under osteoporotic changes could affect the induction of pain-like behaviors in mild OA model mice.
Appendix
Available only for authorised users
Literature
1.
go back to reference Nih Consensus Development Panel on Osteoporosis Prevention D, Therapy (2001) Osteoporosis prevention, diagnosis, and therapy. JAMA 285:785–795CrossRef Nih Consensus Development Panel on Osteoporosis Prevention D, Therapy (2001) Osteoporosis prevention, diagnosis, and therapy. JAMA 285:785–795CrossRef
3.
go back to reference Yoshimura N, Muraki S, Oka H, Mabuchi A, En-Yo Y, Yoshida M, Saika A, Yoshida H, Suzuki T, Yamamoto S, Ishibashi H, Kawaguchi H, Nakamura K, Akune T (2009) Prevalence of knee osteoarthritis, lumbar spondylosis, and osteoporosis in Japanese men and women: the research on osteoarthritis/osteoporosis against disability study. J Bone Miner Metab 27:620–628. https://doi.org/10.1007/s00774-009-0080-8CrossRefPubMed Yoshimura N, Muraki S, Oka H, Mabuchi A, En-Yo Y, Yoshida M, Saika A, Yoshida H, Suzuki T, Yamamoto S, Ishibashi H, Kawaguchi H, Nakamura K, Akune T (2009) Prevalence of knee osteoarthritis, lumbar spondylosis, and osteoporosis in Japanese men and women: the research on osteoarthritis/osteoporosis against disability study. J Bone Miner Metab 27:620–628. https://​doi.​org/​10.​1007/​s00774-009-0080-8CrossRefPubMed
4.
go back to reference Sharma LKD (2007) Epidemiology of osteoarthritis. In: Moskowitz RWAR, Hochberg MC, Buckwalter JA, Goldberg VM (eds) Osteoarthritis: diagnosis and medical/surgical management, 4th edn. Lippincott Williams & Wilkins, Philadelphia, pp 3–26 Sharma LKD (2007) Epidemiology of osteoarthritis. In: Moskowitz RWAR, Hochberg MC, Buckwalter JA, Goldberg VM (eds) Osteoarthritis: diagnosis and medical/surgical management, 4th edn. Lippincott Williams & Wilkins, Philadelphia, pp 3–26
5.
go back to reference Muraki S, Akune T, Oka H, Ishimoto Y, Nagata K, Yoshida M, Tokimura F, Nakamura K, Kawaguchi H, Yoshimura N (2012) Incidence and risk factors for radiographic knee osteoarthritis and knee pain in Japanese men and women: a longitudinal population-based cohort study. Arthritis Rheum 64:1447–1456CrossRefPubMed Muraki S, Akune T, Oka H, Ishimoto Y, Nagata K, Yoshida M, Tokimura F, Nakamura K, Kawaguchi H, Yoshimura N (2012) Incidence and risk factors for radiographic knee osteoarthritis and knee pain in Japanese men and women: a longitudinal population-based cohort study. Arthritis Rheum 64:1447–1456CrossRefPubMed
6.
go back to reference Muraki S, Oka H, Akune T, Mabuchi A, En Yo Y, Yoshida M, Saika A, Suzuki T, Yoshida H, Ishibashi H, Yamamoto S, Nakamura K, Kawaguchi H, Yoshimura N (2009) Prevalence of radiographic knee osteoarthritis and its association with knee pain in the elderly of Japanese population-based cohorts: the ROAD study. Osteoarthr Cartil 17:1137–1143CrossRef Muraki S, Oka H, Akune T, Mabuchi A, En Yo Y, Yoshida M, Saika A, Suzuki T, Yoshida H, Ishibashi H, Yamamoto S, Nakamura K, Kawaguchi H, Yoshimura N (2009) Prevalence of radiographic knee osteoarthritis and its association with knee pain in the elderly of Japanese population-based cohorts: the ROAD study. Osteoarthr Cartil 17:1137–1143CrossRef
10.
go back to reference Glyn Jones S, Palmer AJR, Agricola R, Price AJ, Vincent TL, Weinans H, Carr AJ (2015) Osteoarthritis. Lancet (Br Ed) 386:376–387CrossRef Glyn Jones S, Palmer AJR, Agricola R, Price AJ, Vincent TL, Weinans H, Carr AJ (2015) Osteoarthritis. Lancet (Br Ed) 386:376–387CrossRef
15.
go back to reference Kanaya K, Iba K, Dohke T, Okazaki S, Yamashita T (2016) TRPV1, ASICs and P2X2/3 expressed in bone cells simultaneously regulate bone metabolic markers in ovariectomized mice. J Musculoskelet Neuronal Interact 16:145–151PubMedPubMedCentral Kanaya K, Iba K, Dohke T, Okazaki S, Yamashita T (2016) TRPV1, ASICs and P2X2/3 expressed in bone cells simultaneously regulate bone metabolic markers in ovariectomized mice. J Musculoskelet Neuronal Interact 16:145–151PubMedPubMedCentral
20.
go back to reference Luger NM, Sabino MAC, Schwei MJ, Mach DB, Pomonis JD, Keyser CP, Rathbun M, Clohisy DR, Honore P, Yaksh TL, Mantyh PW (2002) Efficacy of systemic morphine suggests a fundamental difference in the mechanisms that generate bone cancer vs inflammatory pain. Pain 99:397–406CrossRefPubMed Luger NM, Sabino MAC, Schwei MJ, Mach DB, Pomonis JD, Keyser CP, Rathbun M, Clohisy DR, Honore P, Yaksh TL, Mantyh PW (2002) Efficacy of systemic morphine suggests a fundamental difference in the mechanisms that generate bone cancer vs inflammatory pain. Pain 99:397–406CrossRefPubMed
22.
23.
go back to reference Kuttapitiya A, Assi L, Laing K, Hing C, Mitchell P, Whitley G, Harrison A, Howe FA, Ejindu V, Heron C, Sofat N (2017) Microarray analysis of bone marrow lesions in osteoarthritis demonstrates upregulation of genes implicated in osteochondral turnover, neurogenesis and inflammation. Ann Rheum Dis 76:1764–1773CrossRefPubMedPubMedCentral Kuttapitiya A, Assi L, Laing K, Hing C, Mitchell P, Whitley G, Harrison A, Howe FA, Ejindu V, Heron C, Sofat N (2017) Microarray analysis of bone marrow lesions in osteoarthritis demonstrates upregulation of genes implicated in osteochondral turnover, neurogenesis and inflammation. Ann Rheum Dis 76:1764–1773CrossRefPubMedPubMedCentral
24.
go back to reference Orita S, Ishikawa T, Miyagi M, Ochiai N, Inoue G, Eguchi Y, Kamoda H, Arai G, Toyone T, Aoki Y, Kubo T, Takahashi K, Ohtori S (2011) Pain-related sensory innervation in monoiodoacetate-induced osteoarthritis in rat knees that gradually develops neuronal injury in addition to inflammatory pain. BMC Musculoskelet Disord 12:134CrossRefPubMedPubMedCentral Orita S, Ishikawa T, Miyagi M, Ochiai N, Inoue G, Eguchi Y, Kamoda H, Arai G, Toyone T, Aoki Y, Kubo T, Takahashi K, Ohtori S (2011) Pain-related sensory innervation in monoiodoacetate-induced osteoarthritis in rat knees that gradually develops neuronal injury in addition to inflammatory pain. BMC Musculoskelet Disord 12:134CrossRefPubMedPubMedCentral
25.
go back to reference Bingham CO, Buckland Wright JC, Garnero P, Cohen SB, Dougados M, Adami S, Clauw DJ, Spector TD, Pelletier J-P, Raynauld J-P, Strand V, Simon LS, Meyer JM, Cline GA, Beary JF (2006) Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study. Arthritis Rheum 54:3494–3507CrossRefPubMed Bingham CO, Buckland Wright JC, Garnero P, Cohen SB, Dougados M, Adami S, Clauw DJ, Spector TD, Pelletier J-P, Raynauld J-P, Strand V, Simon LS, Meyer JM, Cline GA, Beary JF (2006) Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study. Arthritis Rheum 54:3494–3507CrossRefPubMed
27.
go back to reference Fujita T, Ohue M, Fujii Y, Miyauchi A, Takagi Y (2009) Comparison of the analgesic effects of bisphosphonates: etidronate, alendronate and risedronate by electroalgometry utilizing the fall of skin impedance. J Bone Miner Metab 27:234–239CrossRefPubMed Fujita T, Ohue M, Fujii Y, Miyauchi A, Takagi Y (2009) Comparison of the analgesic effects of bisphosphonates: etidronate, alendronate and risedronate by electroalgometry utilizing the fall of skin impedance. J Bone Miner Metab 27:234–239CrossRefPubMed
28.
go back to reference Laslett LL, Doré DA, Quinn SJ, Boon P, Ryan E, Winzenberg TM, Jones G (2012) Zoledronic acid reduces knee pain and bone marrow lesions over 1 year: a randomised controlled trial. Ann Rheum Dis 71:1322–1328CrossRefPubMed Laslett LL, Doré DA, Quinn SJ, Boon P, Ryan E, Winzenberg TM, Jones G (2012) Zoledronic acid reduces knee pain and bone marrow lesions over 1 year: a randomised controlled trial. Ann Rheum Dis 71:1322–1328CrossRefPubMed
29.
go back to reference Zhu S, Zhu J, Zhen G, Hu Y, An S et al (2019) Subchondral bone osteoclasts induce sensory innervation and osteoarthritis pain. J Clin Investig 129:1076–1093CrossRefPubMed Zhu S, Zhu J, Zhen G, Hu Y, An S et al (2019) Subchondral bone osteoclasts induce sensory innervation and osteoarthritis pain. J Clin Investig 129:1076–1093CrossRefPubMed
30.
go back to reference Akesson K (2003) New approaches to pharmacological treatment of osteoporosis. World Health Organ Bull World Health Organ 81:657–664PubMed Akesson K (2003) New approaches to pharmacological treatment of osteoporosis. World Health Organ Bull World Health Organ 81:657–664PubMed
32.
go back to reference Bonabello A, Galmozzi MR, Bruzzese T, Zara GP (2001) Analgesic effect of bisphosphonates in mice. Pain 91:269–275CrossRefPubMed Bonabello A, Galmozzi MR, Bruzzese T, Zara GP (2001) Analgesic effect of bisphosphonates in mice. Pain 91:269–275CrossRefPubMed
33.
go back to reference Orita S, Ohtori S, Koshi T, Yamashita M, Yamauchi K, Inoue G, Suzuki M, Eguchi Y, Kamoda H, Arai G, Ishikawa T, Miyagi M, Ochiai N, Kishida S, Takaso M, Aoki Y, Toyone T, Takahashi K (2010) The effects of risedronate and exercise on osteoporotic lumbar rat vertebrae and their sensory innervation. Spine (Phila Pa 1976) 35:1974–1982. https://doi.org/10.1097/brs.0b013e3181d5959eCrossRef Orita S, Ohtori S, Koshi T, Yamashita M, Yamauchi K, Inoue G, Suzuki M, Eguchi Y, Kamoda H, Arai G, Ishikawa T, Miyagi M, Ochiai N, Kishida S, Takaso M, Aoki Y, Toyone T, Takahashi K (2010) The effects of risedronate and exercise on osteoporotic lumbar rat vertebrae and their sensory innervation. Spine (Phila Pa 1976) 35:1974–1982. https://​doi.​org/​10.​1097/​brs.​0b013e3181d5959e​CrossRef
34.
go back to reference Roelofs AJ, Thompson K, Ebetino FH, Rogers MJ, Coxon FP (2010) Bisphosphonates: molecular mechanisms of action and effects on bone cells, monocytes and macrophages. Curr Pharm Des 16:2950–2960CrossRefPubMed Roelofs AJ, Thompson K, Ebetino FH, Rogers MJ, Coxon FP (2010) Bisphosphonates: molecular mechanisms of action and effects on bone cells, monocytes and macrophages. Curr Pharm Des 16:2950–2960CrossRefPubMed
35.
go back to reference Hargreaves K, Dubner R, Brown F, Flores C, Joris J (1988) A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32:77–88CrossRefPubMed Hargreaves K, Dubner R, Brown F, Flores C, Joris J (1988) A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32:77–88CrossRefPubMed
36.
go back to reference Honore P, Luger NM, Sabino MA, Schwei MJ, Rogers SD, Mach DB, O’Keefe PF, Ramnaraine ML, Clohisy DR, Mantyh PW (2000) Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord. Nat Med 6:521–528. https://doi.org/10.1038/74999CrossRefPubMed Honore P, Luger NM, Sabino MA, Schwei MJ, Rogers SD, Mach DB, O’Keefe PF, Ramnaraine ML, Clohisy DR, Mantyh PW (2000) Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord. Nat Med 6:521–528. https://​doi.​org/​10.​1038/​74999CrossRefPubMed
Metadata
Title
High bone turnover state under osteoporotic changes induces pain-like behaviors in mild osteoarthritis model mice
Authors
Kenta Kiyomoto
Kousuke Iba
Megumi Hanaka
Koji Ibe
Hikaru Hayakawa
Atsushi Teramoto
Makoto Emori
Toshihiko Yamashita
Publication date
01-11-2020
Publisher
Springer Singapore
Published in
Journal of Bone and Mineral Metabolism / Issue 6/2020
Print ISSN: 0914-8779
Electronic ISSN: 1435-5604
DOI
https://doi.org/10.1007/s00774-020-01124-y

Other articles of this Issue 6/2020

Journal of Bone and Mineral Metabolism 6/2020 Go to the issue

LIST OF REVIEWERS 2019–2020

LIST OF REVIEWERS 2019–2020

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine